Scotts Miracle-Gro: Cyclical Cash, Levered Balance Sheet, Price Already Above the Base Case

The Quarter in Context

Scotts Miracle-Gro reported its fiscal third quarter ended June 27, 2026, on a 10-Q filed August 5, 2026. Net sales for the quarter were $1,172.1 million, up roughly 1.1% from $1,159.3 million in the prior-year quarter, and gross margin compressed slightly to 31.2% from 32.2%. Income from operations fell to $169.6 million from $221.8 million, partly because the quarter absorbed $47.0 million of impairment, restructuring and other charges versus a small credit a year earlier. Diluted EPS came in at $1.90 versus $2.54, and the nine-month diluted EPS of $3.82 trails last year's $5.07.

The single most important context is that this is a seasonally heavy quarter. The company itself states that more than 75% of its North America consumer lawn-and-garden net sales occur in the second and third fiscal quarters, so the quarter's strong cash generation must be read against a much weaker first quarter, which posted a $21.8 million operating loss and a $2.16 diluted loss per share. The nine-month operating cash flow of $195.2 million, not the third quarter alone, is the better measure of cash earned year to date. On top of that, fiscal 2026 reflects a strategic shift: the Hawthorne hydroponic business was classified as a discontinued operation, the North America Hawthorne business was sold to Vireo on April 8, 2026, and the company recorded a $101.8 million pre-tax loss on sale of business in the nine months. The clean continuing-operations view is therefore more representative than the headline net income line.

Business Model and Profit Engine

Scotts Miracle-Gro manufactures, markets and sells branded consumer lawn-and-garden products, principally in North America, under household names such as Scotts, Miracle-Gro, Ortho and Tomcat, and serves as Monsanto's exclusive U.S. marketing agent for consumer Roundup products. The company reports through U.S. Consumer, Other (primarily Canada) and a now-divested Hawthorne segment. Customers are retailers, not end consumers: home centers, mass merchandisers, warehouse clubs, large hardware chains, independent hardware stores, nurseries, garden centers and e-commerce platforms. What those retailers buy is a recurring seasonal basket of fertilizers, grass seed, weed and pest control, soils and mulches, plus Roundup resale rights; this is transactional volume with a recurring seasonal pattern rather than a contracted subscription.

Revenue becomes gross profit through a relatively short manufacturing and distribution chain, then operating profit through SG&A. In the latest quarter, cost of sales was $805.0 million, leaving $365.9 million of gross profit at 31.2%; SG&A of $145.6 million and impairment, restructuring and other of $47.0 million brought operating income to $169.6 million, an operating margin of 14.5%. On the filings, the principal revenue engine is U.S. Consumer; the company does not break out segment economics in the cited excerpts, so the share of profit attributable to U.S. Consumer versus Other cannot be computed from the evidence available and is flagged as a data gap. Pricing power appears modest: revenue grew only ~1% year over year and gross margin contracted ~100 basis points, consistent with a business that competes on brand and retail shelf access rather than unique product technology.

Operating leverage and capital intensity matter because the business is working-capital heavy and seasonal. Inventories were $481.4 million and accounts receivable were $713.0 million at quarter-end against only $27.7 million of cash and $27.7 million of current debt plus $1,836.3 million of long-term debt. The company runs a Master Receivables Purchase Agreement under which it sold $592.9 million of receivables in the quarter for a $5.2 million discount; this is essentially a financing tool that flatters the cash flow statement. Capex is low in dollar terms: $63.1 million in the nine months versus $54.5 million a year ago, but the company does not separate maintenance from growth investment, so any allocation is inference rather than disclosure. The most observable condition that would weaken the profit engine is a weak spring and summer season, which collapses the seasonal revenue peak and leaves fixed SG&A and a $2.1 billion debt stack largely unchanged.

Earnings Quality and Cash Conversion

Where the issuer reports cash flow and capital expenditure cumulatively, the standalone-quarter cash-flow figures are derived by subtracting the preceding cumulative filing. They are calculations from SEC facts rather than separately reported quarterly line items. Operating cash flow for the quarter was $345.6 million on $1,172.1 million of revenue, an unusually high 29.5% cash conversion, but this is the seasonal peak quarter; the nine-month operating cash flow was only $195.2 million on $2,986.1 million of revenue, or about 6.5%. Capital expenditure for the quarter was $24.5 million, producing a quarter free-cash-flow proxy (operating cash flow minus capex) of $321.1 million and a nine-month proxy of $132.1 million. The filings do not split maintenance from growth capex, so this is an accounting free-cash-flow proxy, not a maintenance-capex owner-earnings figure; calling it anything stronger would mis-state the evidence.

Reported net income for the quarter was $112.2 million, but $8.6 million of that came from discontinued operations, including a $32.6 million reduction to the cumulative pre-tax Hawthorne loss. That is a one-time mark-to-market adjustment tied to closing-date valuation of the Vireo non-cash consideration, not recurring earnings. Year-to-date net income is distorted by a $101.8 million loss on the sale of Hawthorne and a $24.8 million income tax expense from discontinued operations. Reported diluted EPS of $1.90 for the quarter includes the Hawthorne tail; the cleaner continuing-operations diluted EPS is $1.75. The earnings quality picture is therefore: the operating engine is generating cash, but reported net income contains meaningful non-recurring items, and the nine-month run-rate is far weaker than the third quarter alone suggests.

Business Quality, Moat, and Industry Position

On the available evidence, the company is best described as an important participant, not a demonstrated core supply-chain bottleneck. This classification describes strategic position only; it is not independent proof of a moat or valuation upside. The defensible assets are real but not unique. The company holds material trademarks (Scotts, Miracle-Gro, Ortho, Tomcat, Hyponex, Earthgro, General Hydroponics, Gavita, Botanicare, Mother Earth) and an active patent portfolio, but the filing explicitly says no single trade secret, patent or group of related patents, alone, is considered critical to the operation of any segment. The stronger economic moat comes from shelf space at the major North American home centers and the exclusive U.S. agency relationship for Monsanto's consumer Roundup brand under the Third Restated Agreement; loss or material decline of that Roundup business is flagged as a substantial source of future earnings risk in the company's own risk factors.

Industry position is that of a dominant brand-led participant in a seasonal, weather-dependent consumer category. Bottleneck characteristics are not core-bottleneck-grade: demand is highly discretionary, capacity can be added by competitors with similar formulations, and the company itself does not assert any technology lead. Important structural features include customer concentration (a small number of large home-center and mass retailers), working-capital intensity (a $713 million accounts receivable balance, partly financed through receivable sales), and a mid-cycle free-cash-flow generation profile that depends on the spring and summer selling window. The supply-chain role is upstream of the retailer but downstream of commodity inputs (urea, resins, sphagnum peat, bark, grass seed), and the company hedges diesel and urea to smooth input cost.

Management and Capital Allocation

Management's capital allocation in fiscal 2026 has been dominated by divestiture. The Hawthorne North America business was sold to Vireo on April 8, 2026 for $97.0 million of non-cash consideration plus a warrant, and the related cash of $35.0 million transferred with the business was treated as an investing outflow. The Hawthorne Netherlands business was sold on September 30, 2025. The company entered a Seventh A&R Credit Agreement on November 21, 2025, providing $2.0 billion of senior secured facilities through November 21, 2030, with a leverage covenant of 5.00x Adjusted EBITDA; the actual leverage ratio was 3.78x at June 27, 2026, and the interest coverage ratio was 5.67x.

Capital return is steady but modest. Dividends paid in the quarter were $38.5 million, consistent with prior quarters, and the year-to-date total was $116.3 million. Share repurchases were only $0.5 million in the quarter and $12.1 million year to date; an authorized $500.0 million repurchase program was announced in December 2025 but is essentially untouched ($500.0 million still available). Long-term debt of $1,836.3 million plus current debt of $277.0 million (the $250.0 million 5.250% Senior Notes due December 15, 2026) totals $2,113.3 million, against $27.7 million of cash and a $208.7 million stockholders' deficit. Total stockholders' equity is negative, a balance-sheet condition worth flagging rather than panicking over because it largely reflects share buybacks at higher historical prices and accumulated other comprehensive losses. Stock-based compensation year to date was $38.3 million versus $55.6 million last year, so compensation dilution is a continuing cost. The qualitative picture is a management team that has chosen to refocus the business, refinance on favorable terms, and hold the dividend while buybacks wait.

Valuation and What the Market Already Expects

At $59.47 per share on September 7, 2026, the dated market capitalization was $3,462.4 million. Net debt is large: $2,113.3 million of total debt minus $27.7 million of cash produces a calculated net debt position of approximately $2,085.6 million on the June 27, 2026 balance sheet. The market is therefore attaching an enterprise value of roughly $5,548 million to a business with a trailing-twelve-month free-cash-flow proxy of $263.3 million, implying a current cash-flow yield of around 4.7%. That is not a demanding level for a steady compounder; for a seasonal, cyclical consumer-products business with a one-time Hawthorne loss still working through the numbers, it requires a real improvement in normalized cash generation to be defensible.

The market-derived share count of 58,220,274 at $59.47 matches the 58,220,274 common shares outstanding reported on the cover of the 10-Q as of July 31, 2026, so no further dilution bridge is needed at the share-count level. The qualitative reverse-DCF question is what operating normalization the $3.46 billion equity price already demands. The current free-cash-flow proxy of $263.3 million is not an annual run-rate that supports today's equity value at any reasonable discount rate without either mid-cycle margin recovery or a re-rating of risk; the dated market capitalization sits above the deterministic base scenario by more than 20%, which leaves no margin of safety at the available price.

Ten-Year Cash Flow to Fair Market Value

The starting free cash flow is the normalized SEC cash-flow proxy, while every growth rate, discount rate and terminal rate below is an explicit editorial assumption rather than company guidance. Each annual cash flow is forecast and discounted separately; terminal value is year-ten free cash flow multiplied by one plus terminal growth, divided by discount rate minus terminal growth, and then discounted back ten years. Fair market capitalization equals that explicit ten-year present value plus discounted terminal value and a same-date balance-sheet adjustment when available. If current cash and debt facts do not share one report date, the table shows the adjustment as unavailable and conservatively applies zero. The share count is derived from the dated market capitalization and share price so US shares and foreign ADRs use a consistent traded-security denominator.

In the reverse-DCF, holding the 9% discount rate and 3% terminal growth fixed, and solving only for one constant growth rate rather than using the base-case growth path, the current market capitalization implies roughly 5.7% annual free cash flow growth for ten years. This is a sensitivity framework, not a price target: the terminal-value share shows how strongly each result depends on assumptions beyond the explicit forecast. Negative margin of safety means the current market capitalization exceeds the scenario value.

Five Value-Investing Lenses

Benjamin Graham Lens

Scotts fails the standard Graham balance-sheet test. Stockholders' equity is negative $208.7 million and total debt of $2,113.3 million sits against only $27.7 million of cash; the $250 million 5.250% Senior Notes due December 15, 2026 are now classified as current debt and management plans to repay them with operating cash plus revolver capacity. The leverage covenant ceiling is 5.00x and the actual reading is 3.78x, so the company is not technically distressed, but a consumer cyclical with negative book equity, a $2.1 billion debt stack, and a heavy first-quarter operating loss does not match the "net-net, low-debt, resilient earnings" profile Graham favored. This is investment only if normalized earnings power is high relative to today's price.

Benjamin Franklin Lens

Franklin's modern application here is capital discipline and opportunity cost. Management has spent the last several years digesting an expensive Hawthorne acquisition, recognizing a $101.8 million loss on its sale, and refinancing to a 2030 maturity wall. The dividend at roughly $154 million per year is a meaningful claim against cash in a business that swings from a $21.8 million first-quarter operating loss to a $169.6 million third-quarter operating profit. The opportunity cost question is whether $154 million of annual dividends plus interest service on $2.1 billion of debt is the best use of cash when the dated share price already requires above-trend free-cash-flow growth to be justified.

Warren Buffett Lens

The Buffett lens asks whether this is a wonderful business at a fair price, or a fair business at a wonderful price. The owner-economics answer is mixed. Trailing-twelve-month free-cash-flow proxy of $263.3 million on an enterprise value of about $5,548 million is a roughly 4.7% pre-tax cash yield, which is not obviously cheap for a cyclical consumer brand with negative book equity and an undefined earnings power base after Hawthorne. The capital-allocation history of buying and writing down Hawthorne is a yellow flag against the management quality Buffett would look for, even if the divestiture itself is a sensible refocus. Owner earnings here depend on whether the $263.3 million is a normal-cycle level or a still-elevated one.

Charlie Munger Lens

Munger would invert: what could make this a permanent loss? The first path is another weak spring, with a $200+ million first-quarter loss followed by a soft seasonal peak, leaving the dividend and the 5.250% Notes refinancing to absorb the strain. The second is loss of the Roundup agency agreement or a material change in its economics, a risk the company itself flags. The third is a return to Hawthorne-style capital misallocation: goodwill of $243.9 million and intangibles of $350.1 million still sit on the balance sheet, and the temptation to redeploy proceeds into another adjacency is real given the company's stated interest in plant care, lighting and indoor growing media brands. Munger would also note that the cognitive temptation is to see a seasonal 31.2% gross-margin quarter and assume the full-year is comparable; it is not.

Li Lu Lens

The Li Lu lens asks whether the business is inside the circle of competence and whether the culture rewards long-term per-share value. Inside the circle, this is a recognizable consumer brands business with a defensible shelf position; it does not require exotic forecasting to understand. Outside the circle, the receivable-sales program ($592.9 million sold in the quarter) and the VIE consolidations of BDH and GDH add accounting complexity that an investor must be willing to track. The durability question is whether the brand moat survives a multi-year period of negative book equity and heavy leverage, and the permanent-loss question is whether a dividend cut or a covenant trip could compress the equity materially if the cycle turns.

Risks, Disconfirming Evidence, and What Would Prove This Thesis Wrong

The first observable thesis breaker would be two consecutive quarters of year-over-year operating margin expansion at the U.S. Consumer level, combined with a return of free-cash-flow proxy above roughly $350 million on a trailing-twelve-month basis, indicating that the post-Hawthorne continuing business has reset to a higher earnings power than the dated price assumes. The second breaker would be evidence of durable pricing power: a full fiscal year of mid-single-digit net sales growth with stable or expanding gross margin, particularly in the lawn fertilizer and grass seed categories. The third breaker would be balance-sheet repair: a meaningful reduction in total debt below $1.8 billion through a combination of operating cash flow and asset sale proceeds, restoring tangible equity and reducing refinancing risk.

The most likely wrong assumption in the analysis above is that the seasonal third quarter's gross margin and cash conversion are representative of the full year; the first quarter's $21.8 million operating loss and the nine-month net income of $225.8 million (with $93.3 million of that from discontinued operations, mostly a loss on sale) make that assumption fragile. Opportunity cost is the alternative: at a current cash-flow yield near 4.7% on enterprise value, capital could be deployed elsewhere with less leverage and a clearer cycle position. Disconfirming evidence already in the filing includes the $47.0 million of impairment, restructuring and other charges in the quarter, the $101.8 million year-to-date loss on the Hawthorne divestiture, and the negative stockholders' equity at June 27, 2026, none of which support a margin-of-safety thesis at $59.47.

Investment Conclusion

Scotts Miracle-Gro at $59.47 is a recognizable consumer brands business with a real but non-unique moat, a heavily seasonal earnings profile, and a balance sheet that includes $2.11 billion of total debt, negative stockholders' equity, and a $250 million note maturing inside twelve months. The dated market capitalization of $3.46 billion sits more than 20% above the deterministic base scenario, so the conclusion cannot be "Fairly valued" or "Attractive with a margin of safety." Given the dated price and the deterministic sensitivity, the supported verdict is Overvalued. The investment conclusion would change to "Worth watching" only if the share price falls meaningfully toward the deterministic base scenario or if the company demonstrates the operating normalization that scenario already assumes.

This article is for educational purposes only and does not constitute investment advice or an offer to buy or sell any security. Market and filing data are as of the dates cited; the valuation analysis is a model output, not an stated forecasts.